PPB Approval

ELREXFIO SOLUTION FOR INJECTION 44MG/1.1ML

Registration Code

HK-68221

Sale Requirement

Prescription only Medicines

Registration Date

May 6, 2024

Company NamePfizer Corporation Hong Kong Limited

Company Information

Company Details

Company NamePfizer Corporation Hong Kong Limited

Company Address

21/F, KERRY CENTRE, 683, KING'S ROAD, QUARRY BAY, HONG KONG

Active Ingredients

Ingredient Name

elranatamab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

ELREXFIO SOLUTION FOR INJECTION 44MG/1.1ML - PPB 批准文号 | MedPath